HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018Leire Pérez‐Latorre, Juan Berenguer, Rafael Micán et al.|Eurosurveillance|2021Cited by 19
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418Alfonso Cabello, Ignacio Valero, Miguel Górgolas et al.|Open Forum Infectious Diseases|2022Cited by 12
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)Daniel Podzamczer, Santiago Moreno, Rafael Micán et al.|Open Forum Infectious Diseases|2021Cited by 7
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysisGundolf Schuettfort, Annette E. Haberl, Jan Borch et al.|HIV Medicine|2025Cited by 1